Clinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer The Nonrandomized Phase 2 VIRO-15 Clinical Trial Article

cited authors

  • Holloway, Robert W.; Mendivil, Alberto A.; Kendrick, James E.; Abaid, Lisa N.; Brown, John V.; LeBlanc, Jane; McKenzie, Nathalie D.; Mori, Kristina M.; Ahmad, Sarfraz

Publication Date

  • May 25, 2023

webpage

published in

category

start page

  • 903

end page

  • 908

volume

  • 9

issue

  • 7